# Moffitt Cancer Center account plan

> Moffitt Cancer Center is a Tampa, Florida NCI Comprehensive Cancer Center with 346 licensed beds and $3,016.8 million of FY2025 revenues.

## At a glance

H. Lee Moffitt Cancer Center & Research Institute is a not-for-profit cancer hospital and research institute in Tampa, Florida, created by the Florida Legislature in 1984 and licensed for 346 general acute care beds. It is a National Cancer Institute Comprehensive Cancer Center and an affiliated teaching hospital of the University of South Florida, drawing most patients from the greater Tampa Bay area. In FY2025 (year to June 30, 2025) total revenues and other support were $3,016.8 million, of which patient service revenues were $2,609.5 million, and income from operations was $127.5 million. It also receives State of Florida appropriations of about $60.2 million a year and a 10% share of Florida cigarette tax collections.

## Business units

- **Moffitt Cancer Center Hospital** (about 87% of FY2025 consolidated revenues ($2,609.9 million)): Provides medical and hospital care, medical education and clinical research in cancer prevention, detection and treatment. It carries almost all of the group's supplies spend ($1,077.5 million) and earned $452.2 million of income from operations in FY2025.
- **Research institute (parent)** (about 9% of FY2025 consolidated revenues ($261.0 million)): Carries basic, translational, prevention and clinical research and provides management services to the subsidiaries. It holds the group's debt and most of its property; federal awards expenditure was $79.5 million in FY2025.
- **Moffitt Medical Group** (about 6% of FY2025 consolidated revenues before eliminations ($169.8 million)): Employs and manages the physicians and medical professionals who staff the Hospital and provide clinical research services, with $156.2 million of patient service revenues.
- **Moffitt Foundation** (about 1% of FY2025 consolidated revenues ($27.9 million)): The principal fundraising organization, with total net assets of $313.0 million.
- **Moffitt Technologies Corporation**: A for-profit subsidiary that manages commercialization of intellectual property developed by the Cancer Center.
- **Pasco County real estate entities**: Moffitt Real Estate Holding Corporation holds land in Pasco County, Florida, the site of the new campus, and Moffitt Lifesciences Campus Management Corporation develops it.

## Strategic priorities

- **Research-led cancer care**: The mission is to contribute to the prevention and cure of cancer; CEO Patrick Hwu frames Moffitt as driving the research that will define the future of care.
- **Pasco County development**: Bond proceeds fund research buildings, proton therapy centers, ambulatory clinics and other capital expenses of the new development in Pasco County, Florida.
- **Capacity expansion**: Purchases of property, plant and equipment reached $318.2 million in FY2025 against $172.4 million in FY2024, with about $380.2 million of remaining estimated costs on projects under way or planned.
- **Mission-driven organization**: The CEO wants every part of the organization, from the lab and bedside to operations, to be mission-driven, and leads by listening to senior leaders and front-line nurses.
- **Commercializing research**: Intellectual property developed by the Cancer Center is commercialized through the for-profit Moffitt Technologies Corporation.

## Investments and deals

- **Capital programme**: $318.2 million of property, plant and equipment purchases in FY2025; construction in progress rose to $311.1 million from $201.4 million.
- **2023A Cigarette Tax bonds**: $325.9 million issued in March 2023 for research buildings, proton therapy centers, Moffitt Ambulatory Clinics and the Pasco County development.
- **2023B Hospital Revenue Bonds**: $200 million issued in September 2023 to fund capital projects; long-term debt totalled $1,153.8 million at June 30, 2025.

## Challenges and risks

- **Reimbursement complexity**: Medicare and Medicaid rules are described as extremely complex, with a reasonable possibility that recorded estimates change by a material amount.
- **Payor and regional concentration**: Managed care payors account for 79% of patient service revenue and most patients come from the greater Tampa Bay area.
- **Rising supply costs**: Supplies grew to $1,108.6 million in FY2025 from $905.5 million in FY2024.
- **Dependence on State support**: State appropriations and Cigarette Tax funds are subject to future legislative support, and grant funding is subject to agency audits.

## What leadership says

> "At places like Moffitt, we don't just treat cancer, we are driving the research that will define the future of care. And right now, it's the time to put the pedal to the metal." — Patrick Hwu, MD, President and CEO, InterView: Patrick Hwu, MD, Tampa Magazine, July 15, 2025

> "My business philosophy is centered around ensuring that every part of the organization is mission-driven." — Patrick Hwu, MD, President and CEO, InterView: Patrick Hwu, MD, Tampa Magazine, July 15, 2025


## Where a supplier can help

- **Construction and facility fit-out**: About $380.2 million of remaining project costs, including research buildings, proton therapy centers and ambulatory clinics in Pasco County, create demand for construction, medical equipment and facility services.
- **Supply chain cost control**: Supplies spend rising to $1,108.6 million makes procurement, pharmacy and inventory optimization a relevant topic.
- **Revenue cycle and reimbursement**: Complex Medicare and Medicaid rules and heavy reliance on managed care payors point to revenue-cycle, coding and payer-contracting support.
- **Research operations and IP commercialization**: The research-led priority and Moffitt Technologies Corporation open room for clinical research platforms, data tools and technology-transfer services.

_Tamtam's reading of the priorities and challenges above, not the company's own words._

## Key documents

### [H. Lee Moffitt Cancer Center & Research Institute, Inc. and Subsidiaries - Consolidated Financial Statements, June 30, 2025 and 2024](https://www.flauditor.gov/pages/nonprofit_forprofit%20rpts/2025%20h%20lee%20moffitt%20cancer%20center%20and%20research%20institute.pdf)

Annual report · 2025-09-26

- H. Lee Moffitt Cancer Center & Research Institute (Tampa, Florida) is a not-for-profit corporation created by the Florida Legislature in 1984, licensed for 346 general acute care beds and designated a National Cancer Institute Comprehensive Cancer Center; it is the parent of the Hospital, the Moffitt Medical Group, the Foundation, Moffitt Technologies and two Pasco County real estate entities.
- FY2025 (year to June 30, 2025): total revenues and other support of $3,016.8 million (FY2024: $2,608.4 million), of which patient service revenues $2,609.5 million (FY2024: $2,259.5 million).
- Income from operations $127.5 million (FY2024: $109.2 million); excess of revenues over expenses $216.6 million after $90.7 million of nonoperating gains (mostly investment income).
- Costs are dominated by salaries, wages, benefits and faculty fees ($1,291.1 million) and supplies ($1,108.6 million, up from $905.5 million), almost all of it incurred in the Hospital.
- Payor mix of patient service revenue: managed care 79%, Medicare 20%, Medicaid/other/commercial/self-pay 1%; most patients come from the greater Tampa Bay area.
- Heavy capital programme: purchases of property, plant and equipment of $318.2 million in FY2025 (FY2024: $172.4 million), construction in progress $311.1 million, and about $380.2 million of remaining estimated costs on projects under way or planned, funded by bonds.
- Long-term debt of $1,153.8 million (hospital revenue bonds and Cigarette Tax Allocation bonds); the 2023A bonds fund research buildings, proton therapy centers, ambulatory clinics and the new development in Pasco County.
- State support: annual appropriations of about $60.2 million and a 10% share of Florida cigarette tax collections from July 2024 to June 2054 (about $38.7 million a year), which secures the Cigarette Tax bonds.
- Balance sheet strength: cash and cash equivalents $524.0 million, total assets $3,835.6 million, net assets $2,204.5 million, an unused $150 million line of credit; unmodified audit opinion by Grant Thornton dated September 26, 2025.

### [InterView: Patrick Hwu, MD (Tampa Magazine)](https://tampamagazines.com/patrick-hwu-interview/)

Executive talk · Patrick Hwu, President and CEO · 2025-07-15

- Patrick Hwu, MD, president and CEO of Moffitt Cancer Center, describes it as the only National Cancer Institute-designated comprehensive cancer center based in Florida.
- He is a tumor immunologist who helped pioneer CAR T-cell therapy in the 1990s and focused on melanoma; trained at the National Cancer Institute under Steve Rosenberg.
- Framing of Moffitt's role: "we don't just treat cancer, we are driving the research that will define the future of care", and "right now, it's the time to put the pedal to the metal".
- His job as CEO: ensure the team has "the resources, support and vision needed" to pursue the mission to prevent and cure cancer.
- Management philosophy: every part of the organization should be mission-driven, from the lab and bedside to operations.
- Leadership method: listening to senior leaders and front-line nurses, which he calls "one of our best tools as a leader".
- Expects Moffitt's lasting impact to come from reducing the cancer death rate through research and patient care and from mentoring the next generation of scientists, clinicians and leaders.
- The piece is a personal profile; it contains no financial figures, targets or project announcements.

## Questions about Moffitt Cancer Center

### What is Moffitt Cancer Center?

A not-for-profit cancer hospital and research institute in Tampa, Florida, designated a National Cancer Institute Comprehensive Cancer Center and licensed for 346 general acute care beds.

### What is Moffitt's revenue?

Total revenues and other support were $3,016.8 million in FY2025 (year to June 30, 2025), including $2,609.5 million of patient service revenues.

### What is Moffitt investing in?

Research buildings, proton therapy centers, ambulatory clinics and a new development in Pasco County, Florida, funded largely by bonds.

### Who leads Moffitt Cancer Center?

Patrick Hwu, MD, a tumor immunologist who helped pioneer CAR T-cell therapy, is President and CEO.

_Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)_
